Found: 73
Select item for more details and to access through your institution.
Impaired response of memory Treg to high density lipoproteins is associated with intermediate/high cardiovascular disease risk in persons with HIV.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1146624
- By:
- Publication type:
- Article
Steady-State Pharmacokinetic Interactions of Darunavir/Ritonavir With Lipid-Lowering Agent Rosuvastatin.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 6, p. 922, doi. 10.1177/0091270011407494
- By:
- Publication type:
- Article
Contributions to early HIV diagnosis among patients linked to care vary by testing venue.
- Published in:
- BMC Public Health, 2008, v. 8, n. 1, p. 220, doi. 10.1186/1471-2458-8-220
- By:
- Publication type:
- Article
Comparison of emergency department HIV testing data with visit or patient as the unit of analysis.
- Published in:
- Journal of Medical Screening, 2009, v. 16, n. 1, p. 29, doi. 10.1258/jms.2009.008086
- By:
- Publication type:
- Article
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Reply to Zhou and Ditangco.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Immune Reconstitution Syndrome in HIV: Validating a Case Definition and Identifying Clinical Predictors in Persons Initiating Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 2006, v. 42, n. 11, p. 1639, doi. 10.1086/503903
- By:
- Publication type:
- Article
A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
- Published in:
- Clinical Infectious Diseases, 2005, v. 41, n. 10, p. 1473
- By:
- Publication type:
- Article
Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 2004, v. 38, n. 10, p. 1485
- By:
- Publication type:
- Article
Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)--Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
- Published in:
- Clinical Infectious Diseases, 2003, v. 37, n. 5, p. 613, doi. 10.1086/378131
- By:
- Publication type:
- Article
Ischemic Cardiovascular Disease in Persons with Human Immunodeficiency Virus Infection.
- Published in:
- Clinical Infectious Diseases, 2002, v. 34, n. 1, p. 98, doi. 10.1086/324745
- By:
- Publication type:
- Article
Serologic Responses to Epitopes of the Major Surface Glycoprotein of Pneumocystis jiroveci Differ in Human Immunodeficiency Virus-Infected and Uninfected Persons.
- Published in:
- Journal of Infectious Diseases, 2002, v. 186, n. 5, p. 644, doi. 10.1086/341565
- By:
- Publication type:
- Article
Level of Cytomegalovirus (CMV) DNA in Cerebrospinal Fluid of Subjects with AIDS and CMV Infection of the Central Nervous System.
- Published in:
- Journal of Infectious Diseases, 1995, v. 172, n. 2, p. 527, doi. 10.1093/infdis/172.2.527
- By:
- Publication type:
- Article
Interpreting and Implementing the 2006 CDC Recommendations for HIV Testing in Health-Care Settings.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
3280 Mycobacterium bovis Bacille-Calmette-Guérin infection aggravates atherosclerosis.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Prevalence of Undiagnosed Acute and Chronic HIV in a Lower-Prevalence Urban Emergency Department.
- Published in:
- American Journal of Public Health, 2014, v. 104, n. 9, p. 1695, doi. 10.2105/AJPH.2014.301953
- By:
- Publication type:
- Article
Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Changes in Fat Mitochondrial DNA and Function in Subjects Randomized to Abacavir-Lamivudine or Tenofovir DF–Emtricitabine With Atazanavir-Ritonavir or Efavirenz: AIDS Clinical Trials Group Study A5224s, Substudy of A5202.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 4, p. 604, doi. 10.1093/infdis/jis720
- By:
- Publication type:
- Article
Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected Adults.
- Published in:
- Journal of Infectious Diseases, 2008, v. 198, n. 9, p. 1345, doi. 10.1086/592169
- By:
- Publication type:
- Article
The Effect of Open-Label Semaglutide on Metabolic Dysfunction–Associated Steatotic Liver Disease in People With HIV.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 6, p. 835, doi. 10.7326/M23-3354
- By:
- Publication type:
- Article
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 12, p. 1676, doi. 10.1093/cid/ciad419
- By:
- Publication type:
- Article
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 11, p. 2010, doi. 10.1093/cid/ciad107
- By:
- Publication type:
- Article
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e613, doi. 10.1093/cid/ciac662
- By:
- Publication type:
- Article
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 2, p. 323, doi. 10.1093/cid/ciac767
- By:
- Publication type:
- Article
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 8, p. 1324, doi. 10.1093/cid/ciac166
- By:
- Publication type:
- Article
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 7, p. 1154, doi. 10.1093/cid/ciac098
- By:
- Publication type:
- Article
Reply to Chu et al.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 5, p. 944, doi. 10.1093/cid/ciab592
- By:
- Publication type:
- Article
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. 2009, doi. 10.1093/cid/ciab552
- By:
- Publication type:
- Article
Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e3384, doi. 10.1093/cid/ciaa1934
- By:
- Publication type:
- Article
Bearing the Burden of Non-AIDS Comorbidities: This Is What Women Aging With Human Immunodefiency Virus Look Like.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 8, p. 1312, doi. 10.1093/cid/ciaa209
- By:
- Publication type:
- Article
COVID-19 Vaccination Rates in a Global HIV Cohort.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article
Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone.
- Published in:
- Journal of Infectious Diseases, 2018, v. 217, n. 11, p. 1770, doi. 10.1093/infdis/jiy064
- By:
- Publication type:
- Article
Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Take Your Best Shot: Which SARS-CoV-2 Vaccine Should I Get?
- Published in:
- MDM Policy & Practice, 2021, v. 6, n. 2, p. 1, doi. 10.1177/23814683211031226
- By:
- Publication type:
- Article
Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 10, p. 1, doi. 10.1093/ofid/ofad467
- By:
- Publication type:
- Article
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 3, p. 1, doi. 10.1093/ofid/ofad106
- By:
- Publication type:
- Article
Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 12, p. 1, doi. 10.1093/ofid/ofac629
- By:
- Publication type:
- Article
Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 12, p. 1, doi. 10.1093/ofid/ofab550
- By:
- Publication type:
- Article
Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 12, p. 1, doi. 10.1093/ofid/ofab537
- By:
- Publication type:
- Article
No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 3, p. N.PAG, doi. 10.1093/ofid/ofz056
- By:
- Publication type:
- Article
Web-Based Data Collection for Older Adults Living With HIV in a Clinical Research Setting: Pilot Observational Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Frequency of Circulating Regulatory T Cells Increases during Chronic HIV Infection and Is Largely Controlled by Highly Active Antiretroviral Therapy.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028118
- By:
- Publication type:
- Article
A RANDOMIZED CONTROL TRIAL OF AN HIV CARE INTERVENTION BUNDLE FOR PEOPLE WITH HIV.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 433
- By:
- Publication type:
- Article
PRE-EXPOSURE PROPHYLAXIS PRODUCT CHOICE IN US PARTICIPANTS IN HPTN 083.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 397
- By:
- Publication type:
- Article
CHANGES IN BODY MASS INDEX WITH INTEGRASE INHIBITOR USE IN REPRIEVE.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 279
- By:
- Publication type:
- Article
EFFICACY AND COMPLEMENTARITY OF HIV-1 SUPPRESSION BY CD4- BINDING bNAbs.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 123
- By:
- Publication type:
- Article
BASELINE AND TEMPORAL DIFFERENCES IN PROTEOMICS FOLLOWING SARS-CoV-2 INFECTION IN PWH.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 110
- By:
- Publication type:
- Article